HK-660S

· CuromeBiosciences

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HK-660S, covering 2023-07-27 to 2025-05-16. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of HK-660S in the Treatment of Primary Sclerosing Cholangitis [Phase 2]